# PANORAMA-1 (NCT01023308)

> Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma

No report yet. It can be ordered.

- Drugs tested: panobinostat
- Indication: relapsed or relapsed and refractory multiple myeloma

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01023308
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Novartis Pharmaceuticals
- Conditions: Multiple Myeloma
- Interventions: Panobinostat; Bortezomib; Dexamethasone; Placebo
- Enrollment: 767
- Primary outcome: Progression-free Survival Events in Patients Treated With Panobinostat in Combination With Bortezomib and Dexamethasone vs. Patients Treated by Placebo in Combination With Bortezomib and Dexamethasone.
- Primary outcome: Progression Free Survival in Patients Treated With Panobinostat in Combination With Bortezomib and Dexamethasone vs. Patients Treated by Placebo in Combination With Bortezomib and Dexamethasone.

## Some of the questions raised in the 9 most recent indexed sources

_Automated from the 9 newest of 10 indexed sources (Oct 2016 – Apr 2025). Each question is raised in at least two. Not an Erudio report: no source links. Not medical advice._

- Whether the results apply to lenalidomide-refractory patients, given how few were enrolled
- How panobinostat-bortezomib-dexamethasone compares with daratumumab-, carfilzomib- or pomalidomide-based regimens across separate trial populations
- Whether panobinostat-bortezomib-dexamethasone keeps a place in relapse sequencing as newer regimens arrive

## Indexed commentary on PANORAMA-1 so far

Podcasts, YouTube videos and posts on X and Bluesky we have indexed that name the trial. LinkedIn posts are read for reports and the Enterprise MCP, not yet for this index. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 10 posts on X

## Order

Focused first edition, $750. Buy the first edition with create_order on https://mcp.erudio.com/mcp (product "first_edition", report "NCT01023308", the buyer's work email and organization), or POST https://www.erudio.com/api/orders with the same fields. It returns a Stripe checkout_url for your person to pay by card; a first edition has no agent-wallet payment. The person can also order on https://www.erudio.com/trials/panorama-1-nct01023308. We build the first edition within 24 hours of payment and email it to you once it passes our checks and review. If your report can't be delivered, we'll contact you and refund it in full.

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT01023308", "email": "<work email>"}; the inbox owner confirms by the emailed link.
